Protagonist Therapeutics Inc (PTGX):企業の財務・戦略的SWOT分析

◆英語タイトル:Protagonist Therapeutics Inc (PTGX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH190876FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥33,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥49,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Protagonist Therapeutics Inc (PTGX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Protagonist Therapeutics Inc (Protagonist) is a clinical-stage biopharmaceutical company that discovers and develops orally stable peptides as targeted therapies. The company through its proprietary technology platform develops structurally novel oral or injectable peptides for protein-protein interaction targets. Protagonist’s peptides specifically target biological pathways that are also targeted by currently marketed injectable antibody drugs. The company’s product candidates are intended for the treatment of inflammatory bowel disease and other gastrointestinal diseases and hematological disorders. It operates in the US and Australia. Protagonist is headquartered in Milpitas, California, the US.

Protagonist Therapeutics Inc Key Recent Developments

Nov 04,2020: Protagonist Therapeutics reports third quarter financial results and provides corporate update
Aug 13,2020: Protagonist appoints Sarah O’Dowd to Board of Directors
Aug 11,2020: Protagonist Therapeutics announces board change
Aug 06,2020: Protagonist Therapeutics reports second quarter financial results and provides corporate update
May 07,2020: Protagonist Therapeutics reports first quarter financial results and provides corporate update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Protagonist Therapeutics Inc – Key Facts
Protagonist Therapeutics Inc – Key Employees
Protagonist Therapeutics Inc – Key Employee Biographies
Protagonist Therapeutics Inc – Major Products and Services
Protagonist Therapeutics Inc – History
Protagonist Therapeutics Inc – Company Statement
Protagonist Therapeutics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Protagonist Therapeutics Inc – Business Description
Protagonist Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Protagonist Therapeutics Inc – Strengths
Protagonist Therapeutics Inc – Weaknesses
Protagonist Therapeutics Inc – Opportunities
Protagonist Therapeutics Inc – Threats
Protagonist Therapeutics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Protagonist Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Protagonist Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Protagonist Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 04, 2020: Protagonist Therapeutics reports third quarter financial results and provides corporate update
Aug 13, 2020: Protagonist appoints Sarah O’Dowd to Board of Directors
Aug 11, 2020: Protagonist Therapeutics announces board change
Aug 06, 2020: Protagonist Therapeutics reports second quarter financial results and provides corporate update
May 07, 2020: Protagonist Therapeutics reports first quarter financial results and provides corporate update
Mar 10, 2020: Protagonist Therapeutics reports fourth quarter and full year 2019 financial results
Nov 06, 2019: Protagonist Therapeutics reports third quarter 2019 financial results
Oct 31, 2019: Protagonist Therapeutics secures debt facility for up to $50 Million
Jun 07, 2019: Protagonist Therapeutics reports second quarter 2019 financial results
May 29, 2019: Protagonist Therapeutics appoints Don Kalkofen as chief financial officer
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Protagonist Therapeutics Inc, Key Facts
Protagonist Therapeutics Inc, Key Employees
Protagonist Therapeutics Inc, Key Employee Biographies
Protagonist Therapeutics Inc, Major Products and Services
Protagonist Therapeutics Inc, History
Protagonist Therapeutics Inc, Subsidiaries
Protagonist Therapeutics Inc, Key Competitors
Protagonist Therapeutics Inc, Ratios based on current share price
Protagonist Therapeutics Inc, Annual Ratios
Protagonist Therapeutics Inc, Annual Ratios (Cont...1)
Protagonist Therapeutics Inc, Interim Ratios
Protagonist Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Protagonist Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Protagonist Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Protagonist Therapeutics Inc (PTGX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Texas Roadhouse Inc (TXRH):企業の財務・戦略的SWOT分析
    Texas Roadhouse Inc (TXRH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Adocia SAS (ADOC):製薬・医療:M&Aディール及び事業提携情報
    Summary Adocia SAS (Adocia) is a biotechnology company that discovers and develops therapeutic proteins. The company provides products such as formulation of PDGF-BB for the treatment of diabetic foot ulcers. It offers novel insulin formulations for the treatment of diabetes and BioChaperone Lispro …
  • Polar Power Inc (POLA):企業の財務・戦略的SWOT分析
    Polar Power Inc (POLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • MorphoSys AG (MOR)-製薬・医療分野:企業M&A・提携分析
    Summary MorphoSys AG (Morphosys) is a developer of monoclonal antibodies for therapeutic, diagnostic and research applications. The company’s pipeline product include MOR208, MOR202, MOR103, MOR209/ES414, MOR106, and MOR107, among others. It drugs are used in the treatment of different types of canc …
  • Natural Alternatives International Inc (NAII):企業の財務・戦略的SWOT分析
    Summary Natural Alternatives International Inc (NAI) is a formulator and manufacturer of customized nutritional supplements. The company manufactures and distributes the only patented beta-alanine supplement on the market. It offers services such as science-based product formulation, raw material ac …
  • Lincoln National Corporation:企業の戦略・SWOT・財務分析
    Lincoln National Corporation - Strategy, SWOT and Corporate Finance Report Summary Lincoln National Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • CA Technologies, Inc.:企業の戦略・SWOT・財務情報
    CA Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary CA Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Diamyd Medical AB (DMYD B):企業の財務・戦略的SWOT分析
    Summary Diamyd Medical AB (Diamyd), formerly Diamyd Therapeutics AB is a drug development company that offers diabetes vaccine. The company's diabetes products include Diamyd, an antigen-based immunotherapy for the treatment of autoimmune diabetes. Its pipeline products include GAD, GABA, and other …
  • Modern Times Group MTG AB:企業のM&A・事業提携・投資動向
    Modern Times Group MTG AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Modern Times Group MTG AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Pacific Edge Ltd (PEB):製品パイプライン分析
    Summary Pacific Edge Ltd (PEB) is a diagnostics company that discovers, develops and commercializes diagnostic tests for the early detection and monitoring of cancer. The company provides lead product such as Cxbladder, a non-invasive laboratory test for the detection of bladder cancer. It is develo …
  • Crescita Therapeutics Inc (CTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Crescita Therapeutics Inc (Crescita Therapeutics) is a commercial dermatology company that offers prescription drug products for the treatment and care of skin conditions and diseases and their symptoms. The company’s products comprise Pliaglis, Alyria, Laboratoire Dr Renaud, Pro-Derm, Premi …
  • Caldera Health Ltd:企業の製品パイプライン分析2018
    Summary Caldera Health Ltd (Caldera) is a biotech company that develops prostate cancer diagnostic tools. The company offers prostate cancer diagnostic and prognostic tests to detect and monitor the cancer disease. It has developed a laboratory test that measures the expression of a range of RNA bio …
  • El Paso Electric Company (EE):電力:M&Aディール及び事業提携情報
    Summary El Paso Electric Company (El Paso) is a vertically integrated electric utility, which generates, transmits, and distributes electric power. It produces electricity from nuclear, natural gas, coal, and solar sources. The company has ownership interest in and operates various power generation …
  • SPI Energy Co Ltd (SPI)-エネルギー分野:企業M&A・提携分析
    Summary SPI Energy Co Ltd (SPI Energy), formerly Solar Power Inc, is a renewable energy company that offers photovoltaic solutions. The company operates in development, financing, installation, operation and sale of utility-scale and residential solar power projects in China. It also operates online …
  • Dana-Farber Cancer Institute Inc-医療機器分野:企業M&A・提携分析
    Summary Dana-Farber Cancer Institute Inc (Dana-Farber), formerly Sidney Farber Cancer Center is a cancer research center that offers treatment for different types of cancers. The center offers adults and children with various treatment options and also focuses on diagnosis, treatment, cure, and prev …
  • Canadian Natural Resources Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Canadian Natural Resources Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Canadian Natural Resources Ltd (Canadian Natural) is an independent upstream oil and gas company. The company carries out acquisition, exploration, development, production, marketing a …
  • Henderson Land Development Co Ltd:企業の戦略・SWOT・財務情報
    Henderson Land Development Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Henderson Land Development Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • University of California San Diego:医療機器:M&Aディール及び事業提携情報
    Summary University of California San Diego (UCSD), a subsidiary of University of California, is a public research university that offers education and research with a portfolio of undergraduate, graduate, postdoctoral and professional schools. It offers courses in various fields including arts and h …
  • Big 5 Sporting Goods Corp:企業の戦略・SWOT・財務分析
    Big 5 Sporting Goods Corp - Strategy, SWOT and Corporate Finance Report Summary Big 5 Sporting Goods Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • M. A. Mortenson Co:戦略・SWOT・企業財務分析
    M. A. Mortenson Co - Strategy, SWOT and Corporate Finance Report Summary M. A. Mortenson Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆